Differential Analysis of Homocysteine and Uric Acid Levels in Patients with Cognitive Impairment Due to Parkinson’s Disease and Post-Stroke Conditions - Takeaways - MDSpire

Differential Analysis of Homocysteine and Uric Acid Levels in Patients with Cognitive Impairment Due to Parkinson’s Disease and Post-Stroke Conditions

  • By

  • Jinbang Zhan

  • Wenfeng Zhang

  • Shuhua Guan

  • Yanan Liu

  • Xiaofen Lin

  • Jinli Yang

  • Weihua Yuan

  • Longyu Zhou

  • Gan Huang

  • April 24, 2026

  • 0 min

Share

  • 1

    The study compared homocysteine and uric acid levels in patients with cognitive impairment due to Parkinson's disease and post-stroke conditions.

  • 2

    Patients with Parkinson's disease and cognitive impairment had significantly higher homocysteine levels and lower uric acid levels than those with post-stroke cognitive impairment.

  • 3

    Elevated homocysteine levels negatively correlated with cognitive function, particularly in the Parkinson's disease group, but uric acid levels showed no significant association.

  • 4

    Low educational attainment, absence of hypertension, and lower uric acid levels were independently associated with Parkinson's disease cognitive impairment.

  • 5

    The findings suggest distinct metabolic profiles for Parkinson's disease and post-stroke cognitive impairment, highlighting the need for further prospective studies.

Original Source(s)

Related Content